{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:54:15Z","timestamp":1787003655952,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Basic Science Research Program of NRF of Korea","award":["NRF-2022R1A6A1A03046247, RS-2024-00451303"],"award-info":[{"award-number":["NRF-2022R1A6A1A03046247, RS-2024-00451303"]}]},{"name":"Basic Science Research Program of NRF of Korea","award":["NRF-2022R1A6A1A03046247, RS-2024-00451303"],"award-info":[{"award-number":["NRF-2022R1A6A1A03046247, RS-2024-00451303"]}]},{"name":"Basic Science Research Program of NRF of Korea","award":["NRF-2022R1A6A1A03046247, RS-2024-00451303"],"award-info":[{"award-number":["NRF-2022R1A6A1A03046247, RS-2024-00451303"]}]},{"name":"Basic Science Research Program of NRF of Korea","award":["NRF-2022R1A6A1A03046247, RS-2024-00451303"],"award-info":[{"award-number":["NRF-2022R1A6A1A03046247, RS-2024-00451303"]}]},{"name":"Basic Science Research Program of NRF of Korea","award":["NRF-2022R1A6A1A03046247, RS-2024-00451303"],"award-info":[{"award-number":["NRF-2022R1A6A1A03046247, RS-2024-00451303"]}]},{"name":"Basic Science Research Program of NRF of Korea","award":["NRF-2022R1A6A1A03046247, RS-2024-00451303"],"award-info":[{"award-number":["NRF-2022R1A6A1A03046247, RS-2024-00451303"]}]},{"name":"Basic Science Research Program of NRF of Korea","award":["RS-2024-00457079"],"award-info":[{"award-number":["RS-2024-00457079"]}]},{"name":"Basic Science Research Program of NRF of Korea","award":["RS-2024-00457079"],"award-info":[{"award-number":["RS-2024-00457079"]}]},{"name":"Basic Science Research Program of NRF of Korea","award":["RS-2024-00457079"],"award-info":[{"award-number":["RS-2024-00457079"]}]},{"name":"Korea Guro hospital research program","award":["K2406771"],"award-info":[{"award-number":["K2406771"]}]},{"name":"Korea Guro hospital research program","award":["K2406771"],"award-info":[{"award-number":["K2406771"]}]},{"name":"Korea Guro hospital research program","award":["K2406771"],"award-info":[{"award-number":["K2406771"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43870-5","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:06:23Z","timestamp":1773939983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic impact of sarcopenia and blood biomarkers in advanced non-small cell lung cancer on first-line immune checkpoint inhibitors"],"prefix":"10.1038","volume":"16","author":[{"given":"Jieun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juwhan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chae Rin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonwoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Kee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"43870_CR1","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.2147\/CMAR.S167400","volume":"10","author":"Y Zhu","year":"2018","unstructured":"Zhu, Y., Zhao, F., Li, Z. & Yu, J. Current landscape and future directions of biomarkers for predicting responses to immune checkpoint inhibitors. Cancer Manag Res. 10, 2475\u22122488 (2018).","journal-title":"Cancer Manag Res."},{"key":"43870_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4046\/trd.2023.0190","volume":"87","author":"DH Kang","year":"2024","unstructured":"Kang, D. H. et al. Immune checkpoint inhibitor score predicts survival benefit of immunotherapy in patients with non-small cell lung cancer. Tuberc Respir Dis. (Seoul). 87, 483\u2212493 (2024).","journal-title":"Tuberc Respir Dis. (Seoul)"},{"key":"43870_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clnu.2023.11.009","volume":"43","author":"Z Lilong","year":"2024","unstructured":"Lilong, Z. et al. Sarcopenia affects the clinical efficacy of immune checkpoint inhibitors in patients with gastrointestinal cancers. Clin. Nutr. 43, 31\u221241 (2024).","journal-title":"Clin. Nutr."},{"key":"43870_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.14283\/jfa.2024.38","volume":"13","author":"T Byrne","year":"2024","unstructured":"Byrne, T. et al. Circulating angiogenic and senescent T lymphocytes in ageing and frailty. J. Frailty Aging. 13, 203\u2212212 (2024).","journal-title":"J. Frailty Aging"},{"key":"43870_CR5","doi-asserted-by":"publisher","first-page":"15039","DOI":"10.3390\/ijms232315039","volume":"23","author":"E Antu\u00f1a","year":"2022","unstructured":"Antu\u00f1a, E. et al. Inflammaging: Implications in sarcopenia. Int. J. Mol. Sci. 23, 15039 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"43870_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.21037\/apm.2018.08.02","volume":"8","author":"MP Davis","year":"2019","unstructured":"Davis, M. P. & Panikkar, R. Sarcopenia associated with chemotherapy and targeted agents for cancer therapy. Ann. Palliat. Med. 8, 86\u2212101 (2019).","journal-title":"Ann. Palliat. Med."},{"key":"43870_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur. J. Cancer. 45, 228\u2212247 (2009).","journal-title":"Eur. J. Cancer"},{"key":"43870_CR8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4235\/agmr.2018.22.2.73","volume":"22","author":"HC Jang","year":"2018","unstructured":"Jang, H. C. How to diagnose sarcopenia in Korean older adults? Ann. Geriatr. Med. Res. 22, 73\u221279 (2018).","journal-title":"Ann. Geriatr. Med. Res."},{"key":"43870_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/cyto.a.24350","volume":"101","author":"TM Ashhurst","year":"2022","unstructured":"Ashhurst, T. M. et al. Integration, exploration, and analysis of high-dimensional single-cell cytometry data using Spectre. Cytometry A. 101, 237\u2212253 (2022).","journal-title":"Cytometry A"},{"key":"43870_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nm.4241","volume":"23","author":"L Gattinoni","year":"2017","unstructured":"Gattinoni, L., Speiser, D. E., Lichterfeld, M. & Bonini, C. T memory stem cells in health and disease. Nat. Med. 23, 18\u221227 (2017).","journal-title":"Nat. Med."},{"key":"43870_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K. et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol. 12, 489\u2212495 (2011).","journal-title":"Lancet Oncol."},{"key":"43870_CR12","doi-asserted-by":"crossref","unstructured":"Gouttefangeas, C. et al. Springer Intl,. Flow cytometry in cancer immunotherapy: Applications, quality assurance, and future. In Cancer Immunology: A Translational Medicine Context (ed. Rezaei, N.) 761\u2212783 (2020).","DOI":"10.1007\/978-3-030-30845-2_33"},{"key":"43870_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/cyto.a.23901","volume":"97","author":"T Kalina","year":"2020","unstructured":"Kalina, T. Reproducibility of flow cytometry through standardization: Opportunities and challenges. Cytometry A. 97, 137\u2212147 (2020).","journal-title":"Cytometry A"},{"key":"43870_CR14","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/cyto.a.24801","volume":"105","author":"T Dott","year":"2024","unstructured":"Dott, T. et al. Standardized high-dimensional spectral cytometry protocol and panels for whole blood immune phenotyping in clinical and translational studies. Cytometry A. 105, 124\u2212138 (2024).","journal-title":"Cytometry A"},{"key":"43870_CR15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.csbj.2020.03.024","volume":"18","author":"P Rybakowska","year":"2020","unstructured":"Rybakowska, P., Alarc\u00f3n-Riquelme, M. E. & Mara\u00f1\u00f3n, C. Key steps and methods in the experimental design and data analysis of highly multi-parametric flow and mass cytometry. Comput. Struct. Biotechnol. J. 18, 874\u2212886 (2020).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"43870_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.4049\/jimmunol.2000854","volume":"206","author":"M Ogishi","year":"2021","unstructured":"Ogishi, M. et al. Multibatch cytometry data integration for optimal immunophenotyping. J. Immunol. 206, 206\u2212213 (2021).","journal-title":"J. Immunol."},{"key":"43870_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","volume":"12","author":"RA Fielding","year":"2011","unstructured":"Fielding, R. A. et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J. Am. Med. Dir. Assoc. 12, 249\u2212256 (2011).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"43870_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.4143\/crt.2021.769","volume":"54","author":"J Choi","year":"2022","unstructured":"Choi, J. et al. Usefulness of pulmonary rehabilitation in non-small cell lung cancer patients based on pulmonary function tests and muscle analysis using computed tomography images. Cancer Res. Treat. 54, 793\u2212802 (2022).","journal-title":"Cancer Res. Treat."},{"key":"43870_CR19","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","volume":"144","author":"S Yuan","year":"2023","unstructured":"Yuan, S. & Larsson, S. C. Epidemiology of sarcopenia: Prevalence, risk factors, and consequences. Metabolism 144, 155533 (2023).","journal-title":"Metabolism"},{"key":"43870_CR20","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1200\/JCO.21.00102","volume":"39","author":"GR Williams","year":"2021","unstructured":"Williams, G. R., Dunne, R. F., Giri, S., Shachar, S. S. & Caan, B. J. Sarcopenia in the older adult with cancer. J. Clin. Oncol. 39, 2068\u22122078 (2021).","journal-title":"J. Clin. Oncol."},{"issue":"Suppl 1","key":"43870_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/gerona\/glad033","volume":"78","author":"SJ Lee","year":"2023","unstructured":"Lee, S. J., Bhasin, S., Klickstein, L., Krishnan, V. & Rooks, D. Challenges and future prospects of targeting myostatin\/activin; A signaling to treat diseases of muscle loss and metabolic dysfunction. J. Gerontol. Biol. Sci. Med. Sci. 78 (Suppl 1), 32\u221237 (2023).","journal-title":"J. Gerontol. Biol. Sci. Med. Sci."},{"key":"43870_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4235\/agmr.19.0028","volume":"23","author":"JY Kwak","year":"2019","unstructured":"Kwak, J. Y. & Kwon, K. S. Pharmacological interventions for treatment of sarcopenia: Current status of drug development for sarcopenia. Ann. Geriatr. Med. Res. 23, 98\u2212104 (2019).","journal-title":"Ann. Geriatr. Med. Res."},{"key":"43870_CR23","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","volume":"391","author":"JD Groarke","year":"2024","unstructured":"Groarke, J. D. et al. Ponsegromab for the treatment of cancer cachexia. N Engl. J. Med. 391, 2291\u22122303 (2024).","journal-title":"N Engl. J. Med."},{"key":"43870_CR24","doi-asserted-by":"publisher","first-page":"900823","DOI":"10.3389\/fnut.2022.900823","volume":"9","author":"S Li","year":"2022","unstructured":"Li, S. et al. Sarcopenia was a poor prognostic predictor for patients with advanced lung cancer treated with immune checkpoint inhibitors. Front. Nutr. 9, 900823 (2022).","journal-title":"Front. Nutr."},{"key":"43870_CR25","doi-asserted-by":"publisher","first-page":"111345","DOI":"10.1016\/j.nut.2021.111345","volume":"90","author":"HY Deng","year":"2021","unstructured":"Deng, H. Y. et al. Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: A comprehensive systematic review and meta-analysis. Nutrition 90, 111345 (2021).","journal-title":"Nutrition"},{"key":"43870_CR26","doi-asserted-by":"publisher","first-page":"112480","DOI":"10.1016\/j.exger.2024.112480","volume":"193","author":"Y He","year":"2024","unstructured":"He, Y. et al. Exploring the impact of interleukins on sarcopenia development: A systematic review and meta-analysis. Exp. Gerontol. 193, 112480 (2024).","journal-title":"Exp. Gerontol."},{"key":"43870_CR27","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3390\/jcm7120502","volume":"7","author":"YC Hou","year":"2018","unstructured":"Hou, Y. C. et al. Elevated serum interleukin-8 level correlates with cancer-related cachexia and sarcopenia: An indicator for pancreatic cancer outcomes. J. Clin. Med. 7, 502 (2018).","journal-title":"J. Clin. Med."},{"key":"43870_CR28","doi-asserted-by":"publisher","first-page":"884592","DOI":"10.3389\/fimmu.2022.884592","volume":"13","author":"XC Mao","year":"2022","unstructured":"Mao, X. C. et al. Peripheral cytokine levels as novel predictors of survival in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Front. Immunol. 13, 884592 (2022).","journal-title":"Front. Immunol."},{"key":"43870_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/vaccines4030022","volume":"4","author":"JM David","year":"2016","unstructured":"David, J. M., Dominguez, C., Hamilton, D. H. & Palena, C. The IL-8\/IL-8R axis: A double agent in tumor immune resistance. Vaccines (Basel). 4, 22 (2016).","journal-title":"Vaccines (Basel)"},{"key":"43870_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2015.3234","volume":"48","author":"X Long","year":"2016","unstructured":"Long, X. et al. IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review) (Review). Int. J. Oncol. 48, 5\u221212 (2016).","journal-title":"Int. J. Oncol."},{"key":"43870_CR31","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.3390\/cancers11091251","volume":"11","author":"SS Cury","year":"2019","unstructured":"Cury, S. S. et al. Tumor transcriptome reveals high expression of IL-8 in non-small cell lung cancer patients with low pectoralis muscle area and reduced survival. Cancers (Basel). 11, 1251 (2019).","journal-title":"Cancers (Basel)"},{"key":"43870_CR32","doi-asserted-by":"publisher","first-page":"215722","DOI":"10.1016\/j.canlet.2022.215722","volume":"539","author":"P Li","year":"2022","unstructured":"Li, P. et al. Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model. Cancer Lett. 539, 215722 (2022).","journal-title":"Cancer Lett."},{"key":"43870_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s42255-022-00538-4","volume":"4","author":"TM Kistner","year":"2022","unstructured":"Kistner, T. M., Pedersen, B. K. & Lieberman, D. E. Interleukin 6 as an energy allocator in muscle tissue. Nat. Metab. 4, 170\u2212179 (2022).","journal-title":"Nat. Metab."},{"key":"43870_CR34","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1111\/febs.12338","volume":"280","author":"P Mu\u00f1oz-C\u00e1noves","year":"2013","unstructured":"Mu\u00f1oz-C\u00e1noves, P., Scheele, C., Pedersen, B. K. & Serrano, A. L. Interleukin-6 myokine signaling in skeletal muscle: A double-edged sword? FEBS J. 280, 4131\u22124148 (2013).","journal-title":"FEBS J."},{"key":"43870_CR35","doi-asserted-by":"publisher","first-page":"580140","DOI":"10.3389\/fcell.2020.580140","volume":"8","author":"Q Huang","year":"2020","unstructured":"Huang, Q., Lei, Y., Li, X., Guo, F. & Liu, M. A highlight of the mechanisms of immune checkpoint blocker resistance. Front. Cell. Dev. Biol. 8, 580140 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"43870_CR36","doi-asserted-by":"publisher","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang, Y., Li, Y. & Zhu, B. T-cell exhaustion in the tumor microenvironment. Cell. Death Dis. 6, e1792 (2015).","journal-title":"Cell. Death Dis."},{"key":"43870_CR37","doi-asserted-by":"publisher","first-page":"101184","DOI":"10.1016\/j.esmoop.2023.101184","volume":"8","author":"A Rousseau","year":"2023","unstructured":"Rousseau, A., Parisi, C. & Barlesi, F. Anti-TIGIT therapies for solid tumors: A systematic review. ESMO Open. 8, 101184 (2023).","journal-title":"ESMO Open."},{"key":"43870_CR38","doi-asserted-by":"publisher","first-page":"833531","DOI":"10.3389\/fimmu.2022.833531","volume":"13","author":"DKJ Pieren","year":"2022","unstructured":"Pieren, D. K. J. et al. Co-expression of TIGIT and Helios marks immunosenescent CD8(+) T cells during aging. Front. Immunol. 13, 833531 (2022).","journal-title":"Front. Immunol."},{"key":"43870_CR39","doi-asserted-by":"publisher","first-page":"e2451093","DOI":"10.1002\/eji.202451093","volume":"54","author":"H Wu","year":"2024","unstructured":"Wu, H., Li, J., Zhang, Z. & Zhang, Y. Characteristics and mechanisms of T-cell senescence: A potential target for cancer immunotherapy. Eur. J. Immunol. 54, e2451093 (2024).","journal-title":"Eur. J. Immunol."},{"key":"43870_CR40","doi-asserted-by":"publisher","first-page":"698076","DOI":"10.3389\/fonc.2021.698076","volume":"11","author":"Y Jin","year":"2021","unstructured":"Jin, Y. et al. Prognostic impact of memory CD8(+) T cells on immunotherapy in human cancers: A systematic review and meta-analysis. Front. Oncol. 11, 698076 (2021).","journal-title":"Front. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43870-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43870-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:29:20Z","timestamp":1780478960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43870-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43870"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43870-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, the authors used ChatGPT (OpenAI) in order to assist with English language editing. After using this tool, the authors reviewed and edited the content as needed, and take full responsibility for the content of the published article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}}],"article-number":"17139"}}